from Global Health Program

A Year Out: Addressing International Impacts of the COVID-19 Pandemic

March 18, 2021

Testimony
Testimony by CFR fellows and experts before Congress.

More on:

COVID-19

Public Health Threats and Pandemics

Pharmaceuticals and Vaccines

United States

Infectious Diseases

In his testimony before the U.S. House of Representatives Committee on Foreign Affairs, Thomas J. Bollyky provides an overview of current engagement of the United States and its allies in addressing the global inequities in vaccine distribution; the emerging circumstances that justify increased U.S. engagement in coronavirus vaccine diplomacy; and a proposal for a U.S.-led initiative to increase the capacity, transparency, and resilience of vaccine manufacturing in order to meet U.S. and global needs.

More on:

COVID-19

Public Health Threats and Pandemics

Pharmaceuticals and Vaccines

United States

Infectious Diseases

Top Stories on CFR

RealEcon

The Federal Reserve’s dual mandate of price stability and maximum employment presents trade-offs as the Fed grapples with the next move of interest rates. 

China

CFR experts discuss President Joe Biden’s decision to increase tariffs on various Chinese imports and the implications for the U.S. economy and U.S.-China relations. 

Myanmar

Myanmar’s civil war between resistance groups and the ruling military junta has reached a decisive phase.